Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 1/2021

29.07.2020 | Original Paper

Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease

verfasst von: Karen Rausch, Gregory M. Scalia, Kei Sato, Natalie Edwards, Alfred King-yin Lam, David G. Platts, Jonathan Chan

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Echocardiographic diagnosis of cardiac amyloidosis (CA) can be difficult to differentiate from increased left ventricular (LV) wall thickness from hypertensive heart disease. The aim of this study was to evaluate left atrial (LA) function and deformation using strain and strain rate (SR) imaging in cardiac amyloidosis. We reviewed 44 cases of CA confirmed by tissue biopsy or a combination of clinical and cardiac imaging data. Cases were classified according two subgroups: amyloid light chain (AL) or amyloid transthyretin (ATTR). These subjects underwent 2D-Speckle tracking echocardiographic derived (STE) LA strain analysis. These were compared to 25 hypertensive (HT) patients with increased LV wall thickness. The three phases of LA function were evaluated using strain and strain rate parameters. Despite a similar increase in LV wall thickness, all LA strain parameters were significantly reduced in the AL cohort compared to the HT cohort (reservoir strain/LAs: 11.0 vs. 24.8%, p < 0.05). The ATTR cohort had significantly thicker LV walls and higher atrial fibrillation burden compared to AL and HT patients but similar reduction in LA strain values compared to AL group. A reservoir strain (S-LAs) cut off value of 20% was 86.4% sensitive and 88.6% specific for detecting CA compared to HT heart disease in this cohort. LA strain parameters were able to identify LA dysfunction in all types of CA. LA function in CA is significantly worse compared with hypertensive patients despite similar increase in LV wall thickness. In combination with other clinical and imaging features, LA strain may provide incremental value in differentiating cardiac amyloidosis from increased wall thickness secondary to hypertension.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Nochioka K, Quarta CC, Claggett B, Roca GQ, Rapezzi C, Falk RH, Solomon SD (2017) Left atrial structure and function in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 18(10):1128–1137PubMed Nochioka K, Quarta CC, Claggett B, Roca GQ, Rapezzi C, Falk RH, Solomon SD (2017) Left atrial structure and function in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 18(10):1128–1137PubMed
2.
Zurück zum Zitat Falk RH, Dubrey SW (2010) Amyloid heart disease. Prog Cardiovasc Dis 52(4):347–361CrossRef Falk RH, Dubrey SW (2010) Amyloid heart disease. Prog Cardiovasc Dis 52(4):347–361CrossRef
3.
Zurück zum Zitat Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A (2013) Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 106(10):528–540CrossRef Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A (2013) Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 106(10):528–540CrossRef
4.
Zurück zum Zitat Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412CrossRef Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404–2412CrossRef
5.
Zurück zum Zitat Shukla A, Wong D, Humphries JA, Fitzgerald BT, Newbigin K, Bashford J, Scalia GM (2017) Transthyretin cardiac amyloidosis: a noninvasive multimodality approach to diagnosis using transthoracic echocardiography, 99m-Tc-labeled phosphate bone scanning, and cardiac magnetic resonance imaging. CASE (Philadelphia, PA) 1(2):49–53 Shukla A, Wong D, Humphries JA, Fitzgerald BT, Newbigin K, Bashford J, Scalia GM (2017) Transthyretin cardiac amyloidosis: a noninvasive multimodality approach to diagnosis using transthoracic echocardiography, 99m-Tc-labeled phosphate bone scanning, and cardiac magnetic resonance imaging. CASE (Philadelphia, PA) 1(2):49–53
6.
Zurück zum Zitat Lee SP, Park JB, Kim HK, Kim YJ, Grogan M, Sohn DW (2019) Contemporary imaging diagnosis of cardiac amyloidosis. J Cardiovasc Imaging 27(1):1–10CrossRef Lee SP, Park JB, Kim HK, Kim YJ, Grogan M, Sohn DW (2019) Contemporary imaging diagnosis of cardiac amyloidosis. J Cardiovasc Imaging 27(1):1–10CrossRef
7.
Zurück zum Zitat Fitzgerald BT, Bashford J, Newbigin K, Scalia GM (2017) Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors. Int J Cardiol Heart Vasculature 14:53–57CrossRef Fitzgerald BT, Bashford J, Newbigin K, Scalia GM (2017) Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors. Int J Cardiol Heart Vasculature 14:53–57CrossRef
8.
Zurück zum Zitat Alexander KM, Evangelisti A, Witteles RM (2019) Emerging therapies for transthyretin cardiac amyloidosis. Curr Treat Options Cardiovasc Med 21(8):40CrossRef Alexander KM, Evangelisti A, Witteles RM (2019) Emerging therapies for transthyretin cardiac amyloidosis. Curr Treat Options Cardiovasc Med 21(8):40CrossRef
9.
Zurück zum Zitat Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007–1016CrossRef Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007–1016CrossRef
10.
Zurück zum Zitat Scalia GM, Scalia IG, Kierle R, Beaumont R, Cross DB, Feenstra J, Burstow DJ, Fitzgerald BT et al (2016) ePLAR - The echocardiographic pulmonary to left atrial ratio - A novel non-invasive parameter to differentiate pre-capillary and post-capillary pulmonary hypertension. Int J Cardiol 212:379–386CrossRef Scalia GM, Scalia IG, Kierle R, Beaumont R, Cross DB, Feenstra J, Burstow DJ, Fitzgerald BT et al (2016) ePLAR - The echocardiographic pulmonary to left atrial ratio - A novel non-invasive parameter to differentiate pre-capillary and post-capillary pulmonary hypertension. Int J Cardiol 212:379–386CrossRef
11.
Zurück zum Zitat Rausch K, Shiino K, Putrino A, Lam AK, Scalia GM, Chan J (2019) Reproducibility of global left atrial strain and strain rate between novice and expert using multi-vendor analysis software. Int J Cardiovasc Imaging 35(3):419–426CrossRef Rausch K, Shiino K, Putrino A, Lam AK, Scalia GM, Chan J (2019) Reproducibility of global left atrial strain and strain rate between novice and expert using multi-vendor analysis software. Int J Cardiovasc Imaging 35(3):419–426CrossRef
12.
Zurück zum Zitat Rausch K, Shiino K, Putrino A, Lam AK, Scalia GM, Chan J (2018) Reproducibility of global left atrial strain and strain rate between novice and expert using multi-vendor analysis software. Int J Cardiovasc Imaging 35:419CrossRef Rausch K, Shiino K, Putrino A, Lam AK, Scalia GM, Chan J (2018) Reproducibility of global left atrial strain and strain rate between novice and expert using multi-vendor analysis software. Int J Cardiovasc Imaging 35:419CrossRef
13.
Zurück zum Zitat Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, ElHamel C, Lavergne D et al (2018) Left atrial function in patients with light chain amyloidosis: a transthoracic 3D speckle tracking imaging study. J Cardiol 71(4):419–427CrossRef Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, ElHamel C, Lavergne D et al (2018) Left atrial function in patients with light chain amyloidosis: a transthoracic 3D speckle tracking imaging study. J Cardiol 71(4):419–427CrossRef
14.
Zurück zum Zitat de Gregorio C, Dattilo G, Casale M, Terrizzi A, Donato R, Di Bella G (2016) Left atrial morphology, size and function in patients with transthyretin cardiac amyloidosis and primary hypertrophic cardiomyopathy- comparative strain imaging study. Circul J 80(8):1830–1837CrossRef de Gregorio C, Dattilo G, Casale M, Terrizzi A, Donato R, Di Bella G (2016) Left atrial morphology, size and function in patients with transthyretin cardiac amyloidosis and primary hypertrophic cardiomyopathy- comparative strain imaging study. Circul J 80(8):1830–1837CrossRef
15.
Zurück zum Zitat Singh A, Addetia K, Maffessanti F, Mor-Avi V, Lang RM (2017) LA Strain for categorization of LV diastolic dysfunction. JACC Cardiovasc Imaging 10(7):735–743CrossRef Singh A, Addetia K, Maffessanti F, Mor-Avi V, Lang RM (2017) LA Strain for categorization of LV diastolic dysfunction. JACC Cardiovasc Imaging 10(7):735–743CrossRef
16.
Zurück zum Zitat Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, Schellberg D, Zugck C et al (2012) Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol 60(12):1067–1076CrossRef Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, Schellberg D, Zugck C et al (2012) Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol 60(12):1067–1076CrossRef
17.
Zurück zum Zitat Koyama J, Falk RH (2010) Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3(4):333–342CrossRef Koyama J, Falk RH (2010) Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3(4):333–342CrossRef
18.
Zurück zum Zitat Fitzgerald BT, Bashford J, Scalia GM (2017) Regression of the anatomic cardiac features of amyloid light chain cardiac amyloidosis accompanied by normalization of global longitudinal strain. CASE (Philadelphia, PA) 1(2):46–48 Fitzgerald BT, Bashford J, Scalia GM (2017) Regression of the anatomic cardiac features of amyloid light chain cardiac amyloidosis accompanied by normalization of global longitudinal strain. CASE (Philadelphia, PA) 1(2):46–48
19.
Zurück zum Zitat Mohty D, Pibarot P, Dumesnil JG, Darodes N, Lavergne D, Echahidi N, Virot P, Bordessoule D et al (2011) Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis. Arch Cardiovasc Dis 104(12):611–618CrossRef Mohty D, Pibarot P, Dumesnil JG, Darodes N, Lavergne D, Echahidi N, Virot P, Bordessoule D et al (2011) Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis. Arch Cardiovasc Dis 104(12):611–618CrossRef
20.
Zurück zum Zitat Tuzovic M, Kobayashi Y, Wheeler M, Barrett C, Liedtke M, Lafayette R, Schrier S, Haddad F et al (2017) Functional cardiac recovery and hematologic response to chemotherapy in patients with light-chain amyloidosis (from the Stanford University Amyloidosis Registry). Am J Cardiol 120(8):1381–1386CrossRef Tuzovic M, Kobayashi Y, Wheeler M, Barrett C, Liedtke M, Lafayette R, Schrier S, Haddad F et al (2017) Functional cardiac recovery and hematologic response to chemotherapy in patients with light-chain amyloidosis (from the Stanford University Amyloidosis Registry). Am J Cardiol 120(8):1381–1386CrossRef
21.
Zurück zum Zitat Sanchis K, Cariou E, Colombat M, Ribes D, Huart A, Cintas P, Fournier P, Rollin A et al (2019) Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality. Amyloid 26(3):128–138CrossRef Sanchis K, Cariou E, Colombat M, Ribes D, Huart A, Cintas P, Fournier P, Rollin A et al (2019) Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality. Amyloid 26(3):128–138CrossRef
22.
Zurück zum Zitat Inaba Y, Yuda S, Kobayashi N, Hashimoto A, Uno K, Nakata T, Tsuchihashi K, Miura T et al (2005) Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 18(7):729–736CrossRef Inaba Y, Yuda S, Kobayashi N, Hashimoto A, Uno K, Nakata T, Tsuchihashi K, Miura T et al (2005) Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 18(7):729–736CrossRef
23.
Zurück zum Zitat Sugimoto T, Robinet S, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L et al (2018) Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 19(6):630–638CrossRef Sugimoto T, Robinet S, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L et al (2018) Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 19(6):630–638CrossRef
24.
Zurück zum Zitat Pathan F, D'Elia N, Nolan MT, Marwick TH, Negishi K (2017) Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr 30(1):59–70.e8CrossRef Pathan F, D'Elia N, Nolan MT, Marwick TH, Negishi K (2017) Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr 30(1):59–70.e8CrossRef
25.
Zurück zum Zitat Liao JN, Chao TF, Kuo JY, Sung KT, Tsai JP, Lo CI, Lai YH, Su CH et al (2017) Age, sex, and blood pressure-related influences on reference values of left atrial deformation and mechanics from a large-scale Asian population. Circ Cardiovasc Imaging 10(10):e006077CrossRef Liao JN, Chao TF, Kuo JY, Sung KT, Tsai JP, Lo CI, Lai YH, Su CH et al (2017) Age, sex, and blood pressure-related influences on reference values of left atrial deformation and mechanics from a large-scale Asian population. Circ Cardiovasc Imaging 10(10):e006077CrossRef
Metadaten
Titel
Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease
verfasst von
Karen Rausch
Gregory M. Scalia
Kei Sato
Natalie Edwards
Alfred King-yin Lam
David G. Platts
Jonathan Chan
Publikationsdatum
29.07.2020
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 1/2021
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-020-01948-9

Weitere Artikel der Ausgabe 1/2021

The International Journal of Cardiovascular Imaging 1/2021 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.